Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has issued a new series of unsecured debt securities, known as Medium-Term Senior Notes, Series N, linked to the performance of NVIDIA Corporation. These Callable Contingent Coupon Equity Linked Securities, detailed in a pricing supplement filed on June 24, 2024, are due on December 30, 2025. The securities offer potential for periodic contingent coupon payments at an annualized rate of 19.50%, which is higher than conventional debt securities of the same maturity. However, investors face risks including the possibility of receiving no contingent coupon payments and receiving less than the principal amount at maturity, depending on NVIDIA's performance. The securities are callable by Citigroup, meaning they can be redeemed before the maturity date...Show More

Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has issued a new series of unsecured debt securities, known as Medium-Term Senior Notes, Series N, linked to the performance of NVIDIA Corporation. These Callable Contingent Coupon Equity Linked Securities, detailed in a pricing supplement filed on June 24, 2024, are due on December 30, 2025. The securities offer potential for periodic contingent coupon payments at an annualized rate of 19.50%, which is higher than conventional debt securities of the same maturity. However, investors face risks including the possibility of receiving no contingent coupon payments and receiving less than the principal amount at maturity, depending on NVIDIA's performance. The securities are callable by Citigroup, meaning they can be redeemed before the maturity date, and do not provide dividends or appreciation from NVIDIA. The securities are not insured or guaranteed by any governmental agency, are not bank deposits, and will not be listed on any securities exchange. The issue price per security is $1,000, with an estimated value at the time of the pricing supplement of $976.90 per security. The offering involves risks detailed in the accompanying product supplement, prospectus supplement, and prospectus.